Research programme: Selective sodium channel blockers - Chromocell Corporation
Latest Information Update: 01 Apr 2024
At a glance
- Originator Chromocell Corporation
- Class Analgesics
- Mechanism of Action Nav1.7 voltage-gated sodium channel inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Ocular pain